Abstract. KARl is required for duplication of the Saccharomyces cerevisiae microtubule organizing center, the spindle pole body (SPB) (Rose, M.D., and G.R. . Cell. 48:1047-1060. Suppressors of a karl allele defective for SPB duplication were isolated in two genes, CDC31 and DSK2 (Vallen, E.A., W.H., M. Winey, and M.D. Rose. 1994. Genetics. 137:407--422). To elucidate the role of DSK2 in SPB duplication, we cloned the gene and found it encodes a novel ubiquitinlike protein containing an NH2 terminus 36% identical to ubiquitin. The only other known yeast ubiquitin-like protein is encoded by the nucleotide excision repair gene RAD23 (Watkins, J.F., P. Sung, L. Prakash, and S. Prakash. 1993. Mol. Cell Bio. 13:7757-7765). Unlike ubiquitin, the NHe-terminal domain of Dsk2p is not cleaved from the protein, indicating that Dsk2p is not conjugated to other proteins. Although the DSK2-1 mutation alters a conserved residue in the Dsk2p ubiquitin-like domain, we detect no differences in Dsk2p or Cdc31p stability. Therefore, DSK2 does not act by interfering with ubiquitin-dependent protein degradation of these proteins. Although DSK2 is not essential, a strain deleted for both DSK2 and RAD23 is temperature sensitive for growth due to a block in SPB duplication. In addition, overexpression of DSK2 is toxic, and the DSK2-1 allele causes a block in SPB duplication. Therefore, DSK2 dosage is critical for SPB duplication. We determined that CDC31 gene function is downstream of DSK2 and KARl. Dsk2p is a nuclearenriched protein, and we propose that Dsk2p assists in Cdc31 assembly into the new SPB.
T hE eukaryotic microtubule cytoskeleton is organized and regulated by microtubule organizing cen-1 .L ters (MTOC). The MTOC of the yeast Saccharomyces cerevisiae (called the spindle pole body [SPB] ) is similar to the centrosome of higher eukaryotes and is essential for microtubule-dependent processes such as mitosis and meiosis (for review see Winey and Byers, 1993) . In addition to their similar functions, the centrosome and SPB are subject to similar cell cycle regulation because they must be duplicated once per cell cycle to form a mitotic spindle. However, despite the functional equivalence between the yeast SPB and the mammalian centrosome, the morphology between the structures is different.
The SPB is a trilaminar structure containing a central plaque, which is physically embedded in the nuclear enve-1. Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; 5-FOA, 5-fluoroorotic acid; GST, glutathione-S-transferase; MTOC, microtubule organizing center; ORF, open reading frame; SC, synthetic complete medium; SPB, spindle pole body; ub-like, ubiquitin-like; YPD, yeast extract/peptone/dextrose medium. lope and inner and outer plaques that nucleate the nuclear and cytoplasmic microtubules, respectively (Byers and Goetsch, 1974, 1975) . A membranous structure, the halfbridge, extends from the central plaque within the nuclear envelope. The entire SPB must faithfully duplicate once per cell cycle to form the poles of the mitotic spindle. At the beginning of the cell cycle, a satellite structure that is thought to be the precusor to the new SPB forms on the outer face of the half-bridge of the sole SPB. The next step is the formation of a new SPB, which is inserted into the nuclear envelope, resulting in adjacent SPBs connected by a complete bridge structure. The bridge is severed in a step that involves kinesin-like motor proteins (Hoyt et al., 1992; Roof et al., 1992) , which act to separate the SPBs to opposite sides of the nucleus to form the poles of the mitotic spindle. After mitosis and cytokinesis, the resulting daughter cells each contain a single SPB. Although SPB duplication once per cell cycle is essential for bipolar mitotic spindle formation, very little is known about the regulation of this essential process.
The Karl protein, a component of the SPB (Vallen et al., 1992b; Spang et al., 1995) , is essential for SPB duplication during the cell cycle . To identify additional proteins involved in SPB duplication, suppressors of a karl allele defective for SPB duplication, karlA17, were isolated (Vallen et al., 1992a (Vallen et al., , 1994 . The MS10  MS1554  MS2082  MS2373  MS2374  MS2645  MS2646  MS3134  MS3137  MS3145  MS3486  MS3487  MS3574  MS3664  MS3759  MY424  MY2259  MY2260  MY2261  MY3316  MY3317  MY3320  MY3321  MY3324  MY3328  MY3329  MY3334  MY3335  MY3516  MY3522  MY3523  MY3545  MY3573  MY3587  MY3588  MY3589  MY3592  MY3602  MY3603  MY3604  MY3714  MY3715  MY3740  MY3741  MY3742  MY3743  MY3752  MY3753  MY3754  MY3755  MY3756  MY3757  MY3758  MY3759  MY4240 dominant extragenic suppressors defined two linkage groups, CDC31 and DSK2. CDC31 encodes a calciumbinding protein (Baum et al., 1986 ) most homologous to centrin/caltractin, a component of the Chlamydomonas reinhardtii MTOC (Huang et al., 1988a,b; Salisbury et al., 1988) . This protein is a conserved component of the MTOC in yeast (Spang et al., 1993; Biggins and Rose, 1994) and other eukaryotic organisms (e.g., Lee and Huang, 1993) . The KARl and CDC31 genes display a number of genetic interactions (Vallen et al., 1994) , and the protein products interact directly in vitro (Biggins and Rose, 1994; Spang et al., 1995) . Although Cdc31p localizes to the SPB in wild-type cells, it was mislocalized in the karlA17 mutant (Biggins and Rose, 1994; Spang et al., 1995) . Suppressor alleles of CDC31 restored SPB localization of Cdc31p, suggesting that Karlp's mitotic function is to recruit and maintain Cdc31p at the SPB. Since some of the suppressors completely bypass the requirement for KARl, suppression cannot be due to an altered interaction between Cdc31p and Karlp. Therefore, it is most likely that the CDC31 suppressors have an increased interaction with another SPB component and no longer require Karlp for SPB localization. Two independent alleles of DSK2 isolated as karlA17 suppressors also bypass the essential function of KARl (Vallen et al., 1994) . The Dsk2p suppressor proteins might directly interact with Cdc31p to localize it to the SPB in a karl deletion strain, or they might act indirectly to bypass the KARl function. To elucidate the role of the DSK2 suppressors in SPB duplication, we cloned DSK2 and found it encodes a novel ubiquitin-like protein.
Ubiquitin is a highly conserved essential 76-amino acid protein that is posttranslationally conjugated to substrates to modify their function (for reviews see Jentsch, 1992; Ciechanover, 1994) . Ubiquitin is synthesized as a fusion protein in which the first 76 amino acids encode ubiquitin and the remainder encodes either other ubiquitins or unrelated proteins that are often involved in protein synthesis. Cellular hydrolases (El enzymes) cleave the primary translation product to generate free ubiquitin, which can then be conjugated to substrate proteins by ubiquitin-conjugating enzymes (E2 enzymes). Substrates can be monoubiquitinated, which may change function, or polyubiquitinated, which targets them for degradation via the proteasome. Conjugation sometimes requires the function of a third protein (E3 ligase).
The ubiquitin-like proteins are a growing family of proteins that contain NH2-terminal domains homologous but not identical to true ubiquitin. Although these proteins have been identified in many organisms, the functions of almost all of them are unknown. One of the major classes of ubiquitin-like genes is involved in DNA repair and includes the yeast gene RAD23 (Watkins et al., 1993) and its human homologues, the XP-C genes (Masutani et al., 1994) . RAD23 was the first ubiquitin-like gene identified in yeast and was originally isolated in a screen for UV-sensitive mutants. A rad23A does not exhibit growth defects but displays an increased sensitivity to UV light (Watkins et al., 1993) . Rad23p is a highly stable nuclear protein, and its function in DNA repair may be to facilitate the interaction between the nucleotide excision repair protein Radl4 and the TFIIH subunit of RNA polymerase (Guzder et al., 1995) . Here we show that DSK2 also encodes a ubiquitinlike protein in which the first 76 amino acids are significantly homologous to ubiquitin and the remainder of the protein does not exhibit homology to any known proteins. In addition, we show that DSK2+ gene function is required with RAD23 function for SPB duplication, and we present models for the potential role of the DSK2+ gene.
Materials and Methods

Microbial Techniques and Yeast Strain Constructions
Yeast media and genetic and microbial techniques were essentially as described in Rose et al. (1990) . Bacterial media was as described in Sambrook et al. (1989) , and bacterial strains XL1-Blue and BL21 were used for all bacterial manipulations. 5-fluoroorotic acid (5-FOA) was used to select Ura-segregants as described by Boeke et al. (1984) .
All yeast strains used are listed in Table I . Yeast strains were constructed by standard genetic techniques. Diploids were selected on the appropriate selective media at 23°C and subsequently sporulated at 23°C. In crosses containing the karlzal7 allele, a KARl+ URA3 plasmid was present to prevent increased ploidy before the cross. After the tetrads were dissected, Ura-derivatives were selected on 5-FOA (Boeke et al., 1984) .
A two-step gene replacement method (Rothstein, 1991) was used to construct a dsk2A strain (MS3574). Plasmid pMR2860 was cut with MscI and transformed into haploid (MS10) and diploid (MS810) strains. Transformants were selected on synthetic complete (SC)-leu media at 23°C and subsequently streaked onto 5-FOA to select -Ura recombinants. To assay for the presence of the dsk2A, PCR analysis was performed with a primer within the LEU2 gene (5' ACA/CCA/TAC/CCA/TCG/TCT 3'; courtesy of Scott Holmes, Princeton University, N J) and a DSK2 primer (5' GGG/ GAG/ACC/TTA/TTT 3'). PCR analysis confirmed the presence of the dsk2A in the haploid strain, indicating that DSK2 is not required for cell viability. The deletion was also confirmed by Western blotting of dsk2A strain (MS3574) extract with anti-Dsk2p antibodies that confirmed the absence of Dsk2p.
A DSK2-1 KARl+ strain was constructed by crossing a DSK2-1 karlA2 strain (MS2646) to a DSK2+ KARl + strain (MS1554). A nonparental ditype from this cross was backcrossed to confirm the genotype as DSK2-1 KARl+. To generate a dsk2A rad23A strain, a rad23A strain (MY3545) marked with URA3 was crossed to a dsk2A strain (MS3574) marked with LEU2. To allow further genetic manipulations with the URA3 marker, a Ura-dsk2A rad23A strain (MY3592) was generated by selecting 5-FOA-resistant segregants of one of the Ura+ Leu+ spores. This was possible because the rad23A marked with URA3 was flanked by direct repeats (Watkins et al., 1993) . To generate a dsk2A karlA17 strain, a DSK2+ karlA17 strain (MS2374) was crossed to a dsk2A KARl + strain (MS3574). To generate a CDC31-16 dsk2A karlzal7 strain, a dsk2A karlD17 strain (MS3664) was crossed to a CDC31-16 karlA17 strain (MS3137). A rad23A karlAl7 strain was generated by crossing a dsk2A rad23A strain (MY3592) to a karlA17 strain (MS2373). To generate a dsk2A rad23A karlA17 strain, a rad23A karlA17 strain (MY3714) was crossed to a dsk2A karlA17 strain (MS3664).
To test suppression of rad23A dsk2A temperature sensitivity by CDC31-16 and high copy CDC31 +, plasmids pMR2023 (2 Ixm, CDC31 +), pMR2223 (2 Ixm, CDC31-16), and pMR1868 (pRS416; Sikorski and Hieter, 1989) were transformed into MY3592 to generate strains MY3602 (pMR2032), MY3603 (pMR2223), and MY3604 (pMR1868). Serial dilutions of the transformants were tested for growth at 37°C and determined that CDC31-16 and high copy CDC31+ suppress the temperature sensitivity of the rad23A dsk2A strain. Strains MY3752-MY3763 were generated and tested for growth at 33 °, 35 °, and 37°C the same way by transforming MY3741.
Growth curves on strains MY3522 and MY3523 were performed by growing them in SC-ura media with 2% raffinose at 30°C to early logarithmic phase. The cultures were split in half, and galactose or glucose was added to each half to 2% final concentration. Aliquots were taken every hour upon galactose or glucose addition, and serial dilutions were plated on SC-ura glucose plates. The viability was calculated as the number of viable cells per ml at each time point. Growth curves on strains MY3587, MY3588, MY3589, and MY3592 were performed the same way, except the strains were grown at 30°C in yeast extract/peptone/dextrose (YPD) media to early logarithmic phase and then shifted to 37°C. Cells were harvested every hour and plated on YPD plates at 30°C.
Plasmid Constructions
All restriction enzymes used in this study were obtained from New England Biolabs (Beverly, MA) and were used according to the supplier specifications. All PCR primers were synthesized at the Princeton University sequencing facility. All cloning techniques were performed according to Sambrook et al. (1989) . DSK2 subclones were obtained by isolating restriction fragments (shown in Fig. 1 A) from the smallest suppressing plasmid (pMR3165) and by ligating them into pRS416 (Sikorski and Hieter, 1989) or YCp50 . To determine which open reading frame (ORF) suppressed karlA17, the URA3 gene was isolated on a 1.1-kb HIII fragment and filled in with Klenow. This was ligated into pMR2719, which had been linearized with Ncol and filled in with Klenow to generate pMR2718 that disrupts ORF2 (shown in Fig. 1 B) .
Glutathione-S-transferase (GST)-Dsk2p bacterial expression plasmids were generated by PCR amplification of the DSK2+ and DSK2-1 genes using primers 5'GGC/AAA/TAA/GAC/GGA/TCC/AAG/ACA/CCG 3' and 5' GAT/AT17ATT/GAT/GGA/TCC/ATG/TAA/TAC 3'. These primers have BamHI sites engineered to allow subsequent digestion and ligation of the PCR products such that the entire DSK2 gene will be expressed. PCR was performed on plasmids pMR2745 (DSK2-1) and pMR2757 (DSK2+), and the 1.8-kb product was digested with BamHI and ligated into the BamHI site of pGEX-KT (courtesy of Steve Haney, Princeton University, N J) to generate pMR2863 (GST-Dsk2-1p) and pMR2862 (GST-Dsk2p). These plasmids were transformed into BL21 to generate strains MR2865 (pMR2862) and MR2863 (pMR2863), which were used for Dsk2p expression and purification to generate antibodies. To generate GST-Dsk2p ubiquitin-like domain fusions, the first 80 amino acids of Dsk2p were cloned into the pGEX-2T vector (courtesy of Steve Haney). PCR was performed on pMR2757 (DSK2+) and pMR2745 (DSK2-1) using primers 5'GGC/AAA/TAA/GAC/GGA/TCC/AAG/ACA/CCG 3' and 5' GGG/GAA/TCC/GGC/GGT/TTG/TGG/TTT/GGG 3'. The 275-bp amplified DNA product was digested with BamHI and EcoRI (sites were engineered into the PCR primers) and cloned into pGEX-2T cut with BamHI/EcoRI (courtesy of Steve Haney) to generate plasmids pMR2908 (GST-Dsk2p ubiquitin-like domain) and pMR2909 (GSTDsk2-1p ubiquitin-like domain). These plasmids were transformed into BL21 to generate strains MR2910 (pMR2908) and MR2911 (pMR2909) for expression and purification of the recombinant proteins.
The full-length DSK2+ and DSK2-1 PCR products described above were cloned into centromere-based vector pRS414 (Sikorski and Hieter, 1989) at the BamHI site and checked for suppression of karlA17 to confirm the presence or absence of the DSK2-1 mutation. These plasmids, pMR2838 (DSK2+) and pMR2859 (DSK2-1), were used to construct galactose-inducible versions of the DSK2 gene. The DSK2 genes were isolated by digestion with BamHI and ligated into pMR613 at the BamHI site. The resulting plasmids, pMR2873 (DSK2-1) and pMR2872 (DSK2+), are 2-~m, URA3 plasmids with DSK2 under the control of the GALl promoter (Yocum et al., 1984) . Centromere-based plasmids were constructed by isolating the PGAL-DSK2 EcoRI/SalI 2-kb fragment from pMR2873 and pMR2872 and ligating it into pMR1868 cut with EcoRI/ XhoI. This generated plasmids pMR2905 (PGaL-DSK2+) and pMR2906 (PcAL-DSK2-1). All experiments reported in this paper used the centromere-based versions of PGAL-DSK2.
DSK2 Deletion and Integration Plasmids
To generate a two-step DSK2 gene replacement plasmid, a series of plasmids were constructed. First, the DSK2+ gene was removed from pMR2757 by digestion with XbaI and BamHI, leaving the 3' flanking 540 bp of the DSK2 gene on the plasmid. This was ligated with the LEU2+ gene isolated as a 2-kb XbaI/BamHI fragment to generate pMR2819. This plasmid was then digested with BamHI, which was ligated with 430 bp of the 5' flanking region of the DSK2 gene (which was PCR amplified using primers 5' GTC/GGA/TCC/GAT/CCG/TCT/TAT/TfG/CCT/CTC/G 3' and 5' CAA/GAA/TCC/CCG/TAG/C 3'). This generated pMR2831, a centromere-based URA3 plasmid containing the LEU2 gene flanked by 3' and 5' DSK2 sequence, pMR2831 was digested with BglII/SpeI to remove the centromere, the ends were filled in with Klenow, and the vector was religated to obtain pMR2860, a vector that can be used for two-step gene replacement of DSK2.
To test linkage between the library clones and the DSK2-1 suppressor, a 2.5-kb XhoI/HIII fragment that suppressed karlA17 was cloned into the LEU2+ integrating vector pRS405 (Sikorski and Hieter, 1989) to generate pMR3161. The plasmid was linearized with NcoI to direct integration into a karlA17 DSK2+ strain (MS2373). The integration was confirmed by Southern analysis. Since the karlA17 allele has a tendency to diploidize (Vallen et al., 1992a) , the strain MS2373 contained a KARl +, URA3 plasmid to ensure spore viability during a cross. After dissection and selection on 5-FOA, the spores were tested for temperature resistance to follow the suppression of the karlA17 allele. Six tetrads segregated 4:0 for temperature resistance, indicating that the suppressing activity present on the integrating DNA corresponded to the DSK2.1 locus. To confirm this, the spores from one tetrad were backcrossed to a karlA17, DSK2+ strain (MS2372) and dissected. Temperature resistance of these spores segregated 2:2, indicating that the authentic DSK2-1 locus had been cloned.
DSK2-1 Library Construction
One liter of strain MS3145 (DSK2-1, karlA17) was grown to OD 600 of 1.7 in YPD and harvested to isolate genomic DNA as described in Gaber et al. (1990) . To construct the library, Sau3A partial enzyme digestions were performed as described in Rose and Broach (1991) and subsequently fractionated on 10-40% sucrose gradients as described in Current Protocols in Molecular Biology (Ausubel et al., 1994) . The 5-10-kb and 10-20-kb fractions from the gradients were pooled and ligated into vector pRS414 (Sikorski and Hieter, 1989) at the BamHI site as described in Rose and Broach (1991) . To amplify the library, ligations were electroporated into strain XL1-Blue (Bullock et al., 1987) and plated on LB-amp plates. At least 35,000 colonies were pooled and DNA was isolated (Sambrook et al., 1989) . Random screening of 20 plasmids indicated at least 60% of the plasmids contain inserts with an average size of 10 kb, representing a library of at least 14 genomes. The library reference numbers are pMR3173-3178.
DSK2 Cloning, Mapping, and Sequencing
The DSK2-1 library was transformed into karlA17 (MS2082), and ~50,000 transformants (representing ~14 genomic equivalents) were grown at 23°C and subsequently replica printed to 37°C. 17 temperatureresistant colonies were isolated, retested, and checked for plasmid-linkage by selecting segregants that lost the plasmid by growth on 5-FOA. All 17 strains depended on the plasmid to be temperature resistant, so the plasmids were isolated from yeast by the method of Hoffman and Winston (1987) , amplified in bacteria, and retransformed into karlA17 (MS2082). All 17 plasmids once again conferred temperature resistance upon karlA17. Restriction mapping indicated the 17 plasmids represented 11 unique plasmids, pMR3162-3172, that contained common internal 1.3-and 4.2-kb RI/HIII fragments. The outer regions were mapped, and the smallest clone, pMR3165, contained ~7 kb as shown in Fig. 1 A.
To localize the DSK2 gene, the subclones shown in Fig. 1 A were constructed, transformed into karlA17 (MS2082), and tested for temperature sensitivity. We found that the 4.2-kb RI/HIII subclone consistently suppressed karlA17 to levels comparable to the DSK2-1 suppressor. Smaller subclones that were constructed (shown in Fig. 1 A) from this 4.2-kb plasmid still suppressed karlA17, but resulted in reduced colony sizes at both 23 ° and 37°C. Therefore, the entire 4.2-kb EcoRI/HIII subclone (pMR3153) that suppressed kar1A17 was sequenced. Decreased colony size observed when the 4.2-kb fragment was further subcloned may be due to toxicity of expressing the NH2 terminus of the adjacent gene (Wolfe, D., and R. Keil, personal communication).
Both strands of the 4.2-kb DSK2 clone were sequenced and can be accessed through EMBL/GenBank/DDBJ accession number L40587. The 1,852 bp that include the DSK2+ gene are shown in this publication. We named the gene adjacent to DSK2 the DAG1 gene (DSK2 adjacent gene), and later learned it corresponds to the ZZZ1 gene that is involved in response to anesthesia (Wolfe, D., and R. Keil, personal communication) . This gene is also entered in GenBank as the BULl gene with accession number D50083. To facilitate DSK2 sequencing, the 4.2-kb subclone was excised from pMR3165 using HIII and ligated into Bluescript vectors (Stratagene, La Jolla, CA) to allow exonuclease III digestions to be performed by the method of Clark and Henikoff (1994) . The exonuclease deletions from clones pMR2833 and pMR2834 were then sequenced using T7 or T3 primers (Princeton University) complementary to the vector DNA with the Sequenase version 2.0 kit supplied by United States Biochemical Corp. (Cleveland, OH) according to double-strand sequencing method provided by the company. Gaps that remained were sequenced with specific primers designed to hybridize to DSK2. Homology searches were performed using the sequence analysis software package by Genetics Computer Group, Inc. (Madison, WI) .
To physically map DSK2, a 300-bp PstI fragment was labeled by the random primer method of Feinberg and Vogelstein (1983) and used to hybridize to lambda prime clone filters provided by Linda Riles (Washington University School of Medicine, St. Louis, MO) according to the provided protocol.
Since the DSK2-1 mutant allele was cloned and sequenced first, the wild-type DSK2+ gene and the DSK2-2 suppressor were recovered by the gap-repair technique (Orr-Weaver et al., 1983) . DSK2 was removed from a centromere-based plasmid containing the DSK2-1 gene by digestion with XbaI and Mcsl. The gapped plasmid was transformed into karlA17 strains containing either the wild-type DSK2+ (MS2082) or DSK2-2 (MS3134) alleles. DNA from the yeast transformants was isolated, and restriction analysis was performed to confirm that the gap was repaired. The gap-repaired plasmids were then transformed into karlA17 (MS2082) to test for suppression of the temperature sensitivity. Plasmids isolated from the wild-type DSK2+ strain (MS2082) did not suppress the karlA17 defect, indicating that the wild-type DSK2+ gene was recovered. Plasmids isolated from the DSK2-2 strain (MS3134) suppressed kar1A17, indicating that the DSK2-2 suppressor was recovered. The DSK2 gene on these plasmids was sequenced, and we found a single base pair difference between the DSK2-1 gene and the DSK2+ gene: codon 69 is changed from a TAT in DSK2-1 to a CAT in DSK2+. The DSK2-2 suppressor contained the same mutation as the DSK2-1 suppressor.
Immunological Techniques
Antibodies against bacterially expressed Dsk2p were generated in two female New Zealand White rabbits at the Princeton University Animal Facility. GST-Dsk2p protein (strain MR2865) was purified according to Smith and Johnson (1988) in the presence of protease inhibitors (chymostatin, leupeptin, aprotinin, pepstatin A, and AEBSF at 2 mg/ml final concentration and PMSF at 1 mM final concentration). AEBSF was obtained from Calbiochem-Novabiochem Corp. (La Jolla, CA), and all other protease inhibitors were from Sigma Chemical Co. (St. Louis, MO). The GST-Dsk2p was eluted from the glutathione beads by competition with 10 mM glutathione (Sigma Chemical Co.) for 60 min at room temperature. The thrombin-cleaved protein was separated on a 10% denaturing polyacrylamide gel and transferred to nitrocellulose (Schleicher & Schuell, Keene, NH), and the band containing Dsk2p was excised. The nitrocellulose strip, which contained at least 0.5 mg of Dsk2p, was dissolved in DMSO. This mixture was emulsified with Freund's complete adjuvant (Sigma Chemical Co.) and injected subcutaneously. Boosts were performed monthly with at least 100 mg of this same mixture emulsified in Freund's incomplete adjuvant (Sigma Chemical Co.).
To purify full-length and NHE-terminal Dsk2p antibodies, GST-Dsk2p and GST-ub-like domain recombinant protein were purified as described above, except the proteins were not thrombin cleaved. Approximately 0.5 mg of the soluble proteins were conjugated to Sulfo-link resin using the Sulfo-link kit (Pierce Chemical Co., Rockford, IL) according to the manufacturer's specifications.
Yeast extracts for Western blotting were prepared according to Ohashi et al. (1982) . For Western blotting, proteins were separated on denaturing polyacrylamide gels, transferred to nitrocellulose (Schleicher & Schuell), and then Western blotted as described in Biggins and Rose (1994) . Affinity purified anti-Dsk2p antibodies were used at a 1:1,000 dilution, affinitypurified anti-Cdc31p antibodies (Biggins and Rose, 1994 ) were used at a 1: 500 dilution, and anti-ubiquitin antibodies (East Acres Biologicals, Southbridge, MA) were used at a 1:1,000 dilution. Secondary antibodies were obtained from Amersham Corp. (Arlington Heights, IL) and used at a 1: 2,000 dilution followed by enhanced chemiluminescence according to manufacturer's directions. For competition experiments, various amounts of purified GST-Dsk2p ubiquitin-like domain recombinant protein were included during the primary incubations.
For the PeAL shut-off experiments, strains MY3520 (pMR2903), MY3521 (pMR2904), MY3522 (pMR2905), MY3523 (pMR2906), and MY3516 (pMR613) were grown overnight at 30°C in SC-ura media with 2% raffinose to early logarithmic phase. Galactose was added to 2% final concentration for 2 h to induce the expression of the Dsk2 proteins. Glucose was then added to 2% final concentration to repress synthesis of the Dsk2 proteins. Equal volumes of ceils were harvested at 0, 3, 7, and 9 h after glucose addition, and protein extracts were prepared and separated on a denaturing polyacrylamide gel. After transfer to nitrocellulose, a Western blot was performed to detect the levels of Dsk2p. As an internal loading control, the blots were also probed with anti-Kar2p antibodies (Rose et al., 1989) .
Partially purified SPBs were prepared in collaboration with Dr. Mark Winey (University of Colorado, Boulder, CO) under the direction of Dr. Mike Rout (Rockefeller University, New York) according to the protocol of Rout and Kilmartin (1990) . Briefly, spheroplasts were made from Saccharomyces uvarum and lysed. A crude nuclear pellet was loaded onto a gradient of layers 2.0, 2.1, and 2.3 M sucrose-polyvinylpyrolidone. The nuclei from the 2.1/2.3 fraction were collected and lysed, and SPBs were subsequently enriched on a step sucrose gradient. The steps in this gradient are: the sample layer, 1.75 M, 2 M, 2.25 M, and 2.5 M sucrose, all as described in Rout and Kilmartin (1990) .
Pulse-chase Experiments
Pulse-chase experiments were performed essentially as described by Gammie et al. (1995) on 4 . 5 0 D units of strains MS1554 and MS3759. The 35S-translabel was added for a pulse of 5 min at 30°C, and 0.5-ml aliquots of cells were removed at 0, 2, 4, 8, and 24 h during the chase. The labeled cells were lysed with glass beads by vortexing in buffer (50 mM Tris-C1, pH 7.4, 100 mM NaC1, 2 mM EDTA, 1 mM PMSF, 1% SDS), boiled for 4 min, and then spun for 10 min in a microfuge. The supernatant was diluted fourfold with buffer (60 mM Tris-C1, pH 7.4, 6 mM EDTA, 190 mM NaCL, 1 mM PMSF, 0.1% Triton X-100) to a final SDS concentration of 0.2%. Two ml of anti-Dsk2p or anti-Cdc31p antibodies were added overnight at 4°C. Protein A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ) was added for 2 h at room temperature, and the beads were then washed twice each with high salt wash (1% Triton X-100, 0.2% SDS, 0.5 M NaC1, 5 mM EDTA, and 50 mM Tris, pH 7.4), IP wash (1% Triton X-100, 0.2% SDS, 5 mM EDTA, and 0.15 M NaC1), and then detergentfree wash. SDS sample buffer (Biggins and Rose, 1994) was added to the beads, and the immunoprecipitates were separated on denaturing polyacrylamide gels, fixed in Amplify (Amersham Corp.) for 30 rain, dried, and autoradiographed.
Microscopy
Indirect immunofluorescence using formaldehyde fixation of intact cells was performed as described by Rose et al. (1990) , and indirect immunofluorescence using MeOH, acetone fixation of spheroplasts, was performed as described by Rout and Kilmartin (1990) . Two different methods of fixation were used because the SPB antibodies do not stain formaldehydefixed cells, and because tubulin antibodies do not stain the methanol, acetone-fixed cells (Rout and Kilmartin, 1990; Biggins and Rose, 1994) . Formaldehyde fixation was for 1 h at 23°C for all strains. Strains MY3516, MY3522, and MY3523 were grown to early logarithmic phase in SC-ura media containing 2% raffinose, and then galactose was added to 2% final concentration for 10 h and harvested for immunofluorescence. Strains MY3587, MY3588, MY3589, and MY3573 were grown to early logarithmic phase in YPD media at 30°C, shifted to 37°C for 6 h, and harvested. Strains MS10, MS3574, and MS3759 were grown to mid-logarithmic phase in YPD media and harvested. Affinity purified anti-Cdc31p antibodies (Biggins and Rose, 1994 ) were used at a 1:1,000 dilution, and affinity-purified anti-Dsk2p antibodies were used at a 1:100 dilution. Anti-90-kD antibodies and rat anti-tubulin antibodies were used at a 1:500 dilution and were the generous gift of John Kilmartin (Medical Research Council, Cambridge, UK). Rabbit anti-tubulin antibodies were also used at a dilution of 1:1,000 and were the generous gift of Frank Solomon (Massachusetts Institute of Technology, Cambridge, MA). Secondary antibodies were used at a 1:1,000 dilution (Boehringer Mannheim Biochemicals, Indianapolis, IN). Secondary antibodies for detection of Cdc31p and Dsk2p were FITC-conjugated goat anti-rabbit IgG. Anti-tubulin secondary antibodies were rhodamine-conjugated goat anti-rat IgG, and anti-90-kD secondary antibodies were rhodamine-conjugated goat anti-mouse IgG. 4',6-diamidino-2-phenylindole (DAPI) was obtained from Accurate Chemicals and Scientific Corp. (Westbury, NY). EM was performed as described in . Strain MY3523 was grown to early logarithmic phase in SC-ura media containing 2% raffinose. Galactose was added to 2% final concentration for 6 h, and cells were harvested for EM. Strain MY4240 was grown to early logarithmic phase in YPD media, shifted to 37°C for 8 h, and harvested for microscopy.
Results
DSK2 Cloning and Mapping
We cloned the DSK2-1 suppressor of the karlA17 mutant to elucidate its role in SPB duplication. Since the DSK2-1 mutation is a dominant karlA17 suppressor with no other known phenotype, a centromere-based library was constructed from the DSK2-1 karlAl7 strain (MS3145) to allow cloning by suppression of the karlzll7 temperature sensitivity. The library was transformed into a karlA17 strain (MS2082) and grown at the permissive temperature of 23°C. To clone the DSK2-1 gene, the colonies were replica printed to the nonpermissive temperature of 37°C and screened for temperature resistance.
Seventeen plasmids were identified that reproducibly conferred temperature resistance upon karlA17 (strain MS2082). Restriction analysis determined that the plasmids contained different overlapping regions of D N A from the same part of the genome. Plasmid integration and a linkage test confirmed that the cloned D N A corresponded to the authentic DSK2 locus. To map the DSK2 gene, a DNA restriction fragment common to all of the plasmids was used for hybridization to lambda-prime clone grid filters provided by Linda Riles. This determined that DSK2 physically maps to the right arm of chromosome XIII near the CDC65 gene.
To narrow down the minimal suppressing region of DNA, the smallest plasmid (~7.5 kb) was restriction mapped, and subclones were constructed (see Fig. 1 A) to test for suppression of karlA17. Only the entire 4.2-kb subclone consistently suppressed karlA17 (Fig. 1 A) so this entire subclone was sequenced. Sequencing indicated that this subclone contained a complete open reading frame (designated ORF2 in Fig. 1 B) and a divergently transcribed partial open reading frame consisting of 776 amino acids (designated ORF1 in Fig. 1 B) . Additional subclones mapped the suppressing activity to a 2-kb D N A fragment that contained the complete open reading frame (ORF2) and a small portion of the partial open reading frame. To determine which reading frame encodes the DSK2 gene, the complete ORF2 was disrupted by inserting the URA3+ gene into the NcoI restriction site (see Fig.  1 B) . This plasmid could not suppress karlA17, indicating the DSK2 gene corresponds to the single complete open reading frame designated ORF2. In addition, this was further confirmed when the DSK2-1 mutation was found to map within this open reading frame (see below). Partial suppression of the smaller subclones was likely to arise from toxicity of the NHE-terminal part of ORF1 (Wolfe, D., and R. Keil, personal communication).
DSK2 Encodes a Ubiquitin-like Gene
The D N A sequence of the RI/HIII fragment is entered into GenBank under accession number LA0587. The DSK2 sequence is shown in Fig. 2 A and encodes an open reading frame of 373 amino acids that is predicted to encode a 41-kD protein. Homology searches indicated significant homology between the first 76 amino acids of Dsk2p and ubiquitin. Dsk2p is 36% identical and 55% similar to the yeast ubiquitin proteins (Ozkaynak et al., 1987;  (Ozkaynak et al., 1987; Watkins et al., 1993) and comprise ubiquitin-like domains. The ubiquitin-like proteins have unique COOH-terminal tail regions (line).
terminal 76 amino acids of Dsk2p identified many ubiquitin homologues that have significant homology to Dsk2p. For example, Dsk2p is 52% similar and 31% identical to the first 76 amino acids of the yeast Rad23 protein (Watkins et al., 1993 ; see Figs. 1 C and 2 B) and 61% similar and 36% identical to the human XP-C proteins (Masutani et al., 1994 ;rdata not shown). Since all ubiquitin proteins are >90% identical and Dsk2p is 36% identical, we classify Dsk2p as a ubiquitin-like protein (see Fig. 1 (Watkins et al., 1993) , the ubiquitin-like domains, are aligned with the yeast ubiquitin protein (Ozkaynak et al., 1987) . Identical residues are indicated by black boxes. The Dsk2p ubiquitin-like domain is 55% similar and 36% identical to ubiquitin and 52% similar and 31% identical to Rad23p. There is no significant homology between the COOH-terminal regions of Dsk2p and Rad23p. Amino acids numbers are indicated above the sequence.
DSK2-1 and DSK2+, which mutates amino acid 69 in the ubiquitin-like domain from a histidine in wild-type DSK2+ to a tyrosine in DSK2-1 (the codon is underlined in Fig. 2 A) . Sequencing of the DSK2-2 suppressor indicated it contains the same mutation as the DSK2-1 suppressor, although the two alleles were isolated independently (Vallen et al., 1994) . It seems likely that the DSK2 suppressor is a very special form of the protein.
The Dsk2p Ubiquitin-like Domain Is Not Cleaved
The homology between Dsk2p and ubiquitin led us to test for similarities between the proteins. Full-length Dsk2p and Dsk2-1p were cloned into bacterial GST expression vectors to allow expression and purification of recombinant Dsk2 protein. When expressed in bacteria, the Dsk2 protein migrates at a molecular weight of ~41,000, consistent with the predicted molecular weight (data not shown). A Western blot was performed with anti-ubiquitin antibodies on the purified bacterial GST-Dsk2 fusion proteins from bacteria and determined that anti-ubiquitin antibodies weakly cross-reacted with the Dsk2 protein but not with GST protein (data not shown).
Since all ubiquitin proteins are synthesized as fusion proteins that are subsequently cleaved by cellular hydrolases to generate free ubiquitin, we tested whether the ubiquitin-like domain is cleaved from the Dsk2 protein.
Ubiquitin has a glycine residue at amino acid 76 that is important for hydrolase recognition, and Dsk2p has a proline residue at this position, suggesting that Dsk2p would not be cleaved by the ubiquitin hydrolases. Nevertheless, a different set of hydrolases might exist to cleave Dsk2p. Polyclonal antibodies were generated against purified Dsk2 recombinant protein and subsequently purified on a bacterial Dsk2p affinity column. A Western blot on a total yeast protein extract using anti-Dsk2p antibodies determined that the Dsk2p antibodies recognize a single band in yeast corresponding to 41 kD (Fig. 3 A, lane 1) . This band is the same molecular weight as the bacterially expressed Dsk2p and is not present in a dsk2A yeast strain (Fig. 3 A, lane 2) . Since the Dsk2p antibodies recognize a single protein of the predicted full-length Dsk2 protein in yeast, the ubiquitin-like domain did not appear to be cleaved.
To rigorously determine whether the ubiqutin-like domain is cleaved, we purified antibodies specific to the NH2-terminal ubiquitin-like (ub-like) domain. A GST fusion containing the Dsk2 ub-like domain was expressed and purified from bacteria and coupled to a column to purify antibodies specific to the Dsk2p ub-like domain. The NH2-terminal antibodies and anti-Dsk2p full-length antibodies were used for Western blotting of total yeast extracts; the ub-like domain antibodies recognized the same band as the full-length antibodies (Fig. 3 B, lane 1) , indicating that the ub-like domain is present on the full-length protein. To confirm that the NH2-terminal antibodies are specific to the ub-like domain, a competition experiment with pure recombinant Dsk2p GST-ub-like protein was performed. Western blotting of total yeast extracts with either Dsk2p NH2-terminal antibodies or full-length antibodies was performed in the presence of increasing amounts of ub-like protein. The Dsk2p GST-ub-like protein fully competed away the Western blot signal of the anti-ub-like antibodies (Fig. 3 C) , indicating that these antibodies are specific to the ub-like domain of Dsk2p. However, the ub-like protein could only partially compete away the signal of the full-length antibodies (Fig. 3 C) , indicating that the full-length antibodies recognize the COOH-terminal domain of Dsk2p.
Dsk2p and Cdc31p Stabilities Are Not Altered by the DSK2-1 Mutation
One of the cellular functions of ubiquitin is to polyubiqui- antibodies are specific to the NH 2 terminus and recognize the same size protein as the full-length antibodies. 0, 0.5, 5, or 50 mg of purified NH2-terminal Dsk2 protein (indicated above the blots) was incubated with either NH2-terminal Dsk2p antibodies or full-length antibodies during Western blotting of wild-type yeast strains. The Western blot shows that 0.5 mg of pure NH2-terminus is sufficient to compete away the binding of the NH 2-terminal Dsk2p antibodies, but 50 mg of NH2-terminal protein cannot fully compete away the binding of the full-length Dsk2p antibodies. Therefore, the NH2-terminal antibodies are specific to the NH2 terminus and recognize the same protein as the fulllength antibodies, showing that the ubiquitin-like domain of Dsk2p is not cleaved. tinate substrates on one or more lysine residues to cause substrate degradation via the proteasome (for review see Ciechanover, 1994) . Although the details of this process are not completely understood, site-directed mutagenesis on ubiquitin was performed to define residues that are important for the resulting degradation of substrates (Ecker et al., 1987) . In this study, it was determined that one of the ubiquitin residues important in the subsequent degradation of substrates is histidine-68. When this residue was mutated to a lysine, the BSA substrate that was conjugated to the mutant ubiquitin was only degraded at 30% the rate of wild-type ubiquitin-conjugated BSA. Although the mechanism of the change in stability is unknown, the mutation in ubiquitin somehow decreases substrate proteolysis. Since both the DSK2-1 and DSK2-2 mutations change histidine-69 (which corresponds to the ubiquitin histidine 68) to a tyrosine, it was possible that they affect the stability of a ubiquitinated protein by inhibiting proteolysis.
We therefore tested the stability of Dsk2p and Cdc31p in D S K 2 + and DSK2-1 strains since mutations in both genes suppress the karl A17 temperature sensitivity. Pulsechase experiments were performed on wild-type (MS1554) and DSK2-1 (MS374) strains by adding 35S-translabel for 5 min and harvesting cells at different times during the chase. The cells were lysed, and immunoprecipitations with anti-Dsk2p and anti-Cdc31p were performed, separated on denaturing gels, and subjected to autoradiography to determine the amount of labeled protein. This determined that both Cdc31p (Fig. 4 A) and Dsk2p (Fig. 4 B) have very long half-lives (>8 h) in wild-type and DSK2-1 strains, so a change in their stability is unlikely to be the (A and B) A pulse-chase experiment was performed on DSK2+ and DSK2-1 strains to determine the stability of Cdc31p and Dsk2p. Equivalent volumes of labeled cells were harvested at 0, 2, 4, and 8 h (indicated above the blots), and proteins were immunoprecipitated with anti-Cdc31p (A) or antiDsk2p (B) antibodies. The proteins were resolved on denaturing polyacrylamide gels and subjected to autoradiography that indicated no differences in stability between the strains. (C) A PGAL-DSK2 shut-off experiment. The DSK2 + and DSK2-1 genes were placed under the control of the galactose-inducible GALl promoter and expressed in dsk2A strains as the sole source of Dsk2 protein. Protein synthesis was repressed by the addition of glucose to the media, and equivalent numbers of cells were harvested at 0, 3, 7, 9, and 23 h (indicated above the blots) after the addition of glucose. Extracts from the cells were prepared, separated on a denaturing polyacrylamide gel, and transferred to a membrane. Western blots of the membrane with anti-Dsk2p antibodies are shown and indicate that the stability of the Dsk2p and Dsk2-1 proteins is equivalent.
• mechanism of DSK2-1 suppression of karlA17. We also tested the stability of Cdc31p and Dsk2p in a karlzll7 strain at the permissive and nonpermissive temperatures by pulse-chase to determine whether their stability was altered during suppression. Again, the half-lives of Cdc31p and Dsk2p were very long and therefore unlikely to be relevant to the suppression (data not shown). In addition, pulse-chase experiments with very short and long time points were conducted, and we did not detect the presence of any alternative forms of Dsk2p, supporting our observation that the NH2-terminal domain of Dsk2p is not cleaved (see above).
To determine by an alternative method whether Dsk2p and Dsk2-1p have equal half-lives, a galactose shut-off experiment was performed. The D S K 2 + and DSK2-1 genes were placed under the control of the galactose inducible G A L l promoter (Yocum et al., 1984) . They were transformed into a dsk2A strain (MS3574, see below) and grown in galactose for 2 h to induce expression of the Dsk2 proteins. Glucose was added to repress further synthesis of the proteins, and aliquots of cells were harvested at various time points. When equal numbers of cells were subjected to a Western blot with anti-Dsk2p antibodies to monitor the protein levels, the turnover rate of Dsk2p and Dsk2-1p appeared to be equivalent (Fig. 4 C) .
DSK2-1 Requires the COOH-terminai Tail for Function
Since the DSK2-1 mutation maps to the ubiquitin-like domain, we tested whether the ub-like domain is sufficient for the suppression of karlA17. The wild-type and DSK2-1 ub-like domains were cloned into a centromere-based yeast vector under the control of the regulated galactose promoter. They were then transformed into wild-type (MS1554) and karlA17 (MS2082) strains. To check that the ub-like proteins are expressed and stable, the strains were grown in the presence of galactose, and yeast extracts from these strains were prepared and separated on denaturing gels. The proteins were transferred to membranes and probed with anti-Dsk2p antibodies to detect the protein. The proteins were expressed to the same level as the full-length Dsk2p (data not shown). These strains were then grown at 37°C to test for suppression of karlA17. The ub-like domain of DSK2+ and DSK2-1 did not suppress karlzal 7, indicating that the tail of the protein is important for the suppression (data not shown). In addition, the overexpression of the truncated proteins was not toxic, unlike overexpression of the full-length protein (see below).
DSK2 and RAD23 Are Involved in SPB Duplication
To learn more about the function of the DSK2 gene, a two-step gene replacement method (Orr-Weaver et al., 1983) was used to delete the entire DSK2 gene. The deletion did not affect growth rate at temperatures ranging from 23 ° to 37°C. Since the dsk2A had no detectable phenotype, it seemed possible this might be due to functional redundancy with another gene(s) such as the ubiquitinlike gene, RAD23. Although a rad23A strain is UV sensitive (Watkins et al., 1993) , it displays no growth defects at temperatures ranging from 23 ° to 37°C. To test for functional redundancy between the ubiquitin-like genes, we generated a rad23A dsk2A double mutant. The growth rate of the double mutant was normal at 23 ° and 33°C (Table  II) , but growth was severely inhibited at 35 ° and 37°C (Table II). Growth curves were performed on wild-type, dsk2A, rad23A, and dsk2A rad23A strains at 37°C. The dsk2A, rad23A, and wild-type strains had similar growth rates (Fig. 5 A) . Growth of the dsk2A rad23A double mutant arrested within i h after the shift to the nonpermissive temperature (Fig. 5 A) .
To determine whether the temperature-sensitive defect in the dsk2A rad23A double mutant was due to a defect in SPB function, indirect immunofluorescence was performed to visualize the microtubules, the SPBs, and Cdc31p localization. Wild-type, dsk2A, rad23A, and dsk2za rad23A strains were grown to early logarithmic phase at 30°C, shifted to 37°C for 6 h, and formaldehyde fixed for indirect immunofluorescence. The wild-type and single mutant strains had normal distributions of cells in each phase of the cell cycle (Fig. 5 C) . In the rad23A dsk2A strain, there was an increase in large-budded cells to 47% (compared to 11% in the isogenic wild-type strain; Fig. 5  C) . DAPI staining to visualize the nucleus in these cells showed that the nucleus was abnormally positioned in the neck of the large-budded cells, resulting in a "cut" phenotype (Fig. 6 K) . In contrast, the wild-type, rad23A, and dsk2A strains had either an elongated nucleus or two nuclei in large-budded cells (Fig. 6, B, E, and H) . The rad23A strain had a small percentage (5%) of large-budded cells with a single nucleus positioned in the neck (Fig. 5 C) . Immunofluorescent staining of tubulin to visualize the microtubules determined that the wild-type, dsk2A, and rad23A strains had wild-type cytoplasmic and nuclear microtubule morphology (Fig. 6, C, F, and/) . In large-budded cells, the microtubules in these strains extended between the two nuclei, indicating the presence of an elongated bipolar mitotic spindle (Fig. 6, C, F, and/) . The small percentage of large-budded cells with the cut phenotype in the rad23A strain contained a short bipolar spindle that extended between the two edges of the nucleus as defined by the DAPI staining (data not shown). In contrast, the largebudded cells in the dsk2A rad23A strain had a single vertex of microtubules on the edge of the nucleus, indicating the presence of a monopolar spindle (Fig. 6, L) . This defect suggested that the large-budded cells in the dsk2A rad23A strain had either a single SPB or duplicated SPBs that had not separated.
To visualize the SPBs, indirect immunofluorescence was performed using anti-90-kD antibodies generated against partially purified SPBs by Rout and Kilmartin (1990) or anti-Cdc31p antibodies (Biggins and Rose, 1994) . Staining with SPB antibodies on wild-type, dsk2A, and rad23A strains was normal: the distribution of cells with one and two SPBs matched expectations based on the distribution of cells in the cell cycle (Fig. 5 C) . Unbudded cells and a few small-budded cells should have a single SPB, and all other cells should have two SPBs. In wild-type, dsk2A, and rad23A strains, ~60% of the cells had a single SPB as visualized as a dot of 90-kD staining (Fig. 7, B , D, and F) on the edge of the nucleus as defined by DAPI staining (Fig.  7 , A, C, and E). This percentage correlates well with the ~60% unbudded cells (Fig. 5 C) . In contrast, there was an increase in the percentage of cells containing a single SPB from 60% to 87% in the dsk2A rad23A strain at 37°C (Figs. 5 C and 7 H). We attribute the increase to 87% of single SPBs to the increase in large-budded cells with a monopo- age of cells containing one or two SPBs was calculated by counting >200 cells that were stained with anti-SPB antibodies (90-kD or Cdc31p). The experiment was performed twice, and the averages of both experiments are reported. The same experiment was performed on cells containing the DSK2+ and DSK2-1 genes under control of the GALl promoter. The genes were overexpressed by growth in galactose for 10 h and processed as described above. lar spindle observed by tubulin staining. Few cells were ever seen in the dsk2A rad23A strain with adjacent SPBs, suggesting the monopolar tubulin staining is due to cells with unduplicated SPBs. To determine whether the monopolar spindles in the dsk2A rad23A strain contain a single SPB or duplicated but unseparated SPBs, EM was performed. Serial sections of 11 large-budded cells with a single nucleus were analyzed. Each cell was followed through six to twelve sections. Seven of these cells (66%) contained a single SPB (Fig. 8, A and B) . Absence of a second SPB in the preceding and subsequent sections confirmed that the SPB had not duplicated. The unduplicated SPBs were often enlarged and embedded within a deep invagination of the nucleus (Fig. 8, A and B) , resembling the phenotype of karl and cdc31 (Byers, 1981) mutants. The four remaining cells contained duplicated SPBs, either in a bipolar configuration (three of the four cells) or in a side by side configuration (one of the four cells) (data not shown). These results are in close agreement with the immunofluorescence data in which ~60% of the largebudded cells contained a monopolar spindle (Fig. 5 C) . Therefore, the monopolar cell cycle block of the dsk2A rad23A strain was due to a block in SPB duplication.
Since the temperature-sensitive defect of karlA17 results in a SPB duplication defect due to mislocalization of Cdc31p, we tested whether Cdc31p was properly localized to the SPB in the rad23A dsk2A strain at 37°C. In all four strains, Cdc31p staining always colocalized with the 90-kD staining, indicating that Cdc31p localization is not altered in the double mutant (data not shown).
We next tested whether the CDC31 mutant suppressors of karlA17 suppressed the temperature sensitivity of the dsk2A rad23A strain. This would indicate that the defect involved CDC31 function. We found that both CDC31-16 and high copy CDC31+ suppressed the rad23A dsk2A temperature-sensitive strain at 35°C but not at 37°C (Table  II) . In addition, we isolated CDC31+ multiple times in a screen for high copy suppressors of the temperature-sensitive defect of the rad23A dsk2A double deletion strain (Ivanovska, I., and M. Rose, unpublished results). Therefore, the dsk2A rad23A defect is at least partly mediated through Cdc31p.
Since RAD23 is functionally redundant with DSK2 for SPB duplication, we tested whether DSK2 has a role in D N A repair like RAD23. To do this, wild-type, rad23A, dsk2A, and rad23A dsk2A strains were plated and subjected to increasing UV light. We found that the rad23A and rad23A dsk2A strains were both equally UV sensitive, and the dsk2A strain was not UV sensitive (data not shown).
DSK2 0verexpression Blocks SPB Duplication
The overexpression of the Karlp SPB component is toxic and causes a large-budded arrest with a monopolar spindle . Indirect immunofluorescence on overexpressed Karlp indicates it forms a large aggregate that is no longer localized to the SPB . Cdc31p is associated with this aggregate (Biggins and Rose, 1994) , suggesting that the block in SPB duplication by overexpression of K A R l may be due to a titration of SPB components away from the SPB. To determine if DSK2 overexpression has phenotypes similar to K A R l overexpression, we constructed plasmids in which both DSK2+ and DSK2-1 were placed under the control of the G A L l promoter (Yocum et al., 1984) . When high levels of Dsk2p were induced by growth on galactose plates, growth was inhibited. To carefully assess the growth defects of overexpression of DSK2+ and DSK2-1, growth curves were performed in the presence and absence of galactose. Cells from both strains were grown to early logarithmic phase in the presence of raffinose. Glucose was added to half of the culture, galactose was added to the other half, and cells were plated for viability on glucose plates every hour for 10 h. The cessation of growth indicated that overexpression of both DSK2+ and DSK2-1 was toxic (Fig. 5 B) .
To determine if the toxicity of DSK2 overexp~ssion was due to a defect in SPB duplication, cells were grown in galactose or glucose for 10 h and processed for indirect immunofluorescence as described above. In the overexpressed DSK2 strains (Fig. 5 C) , there was an increase in the percentage of large-budded cells. Wild-type cultures had 11% large-budded cells while PGAL-DSK2+ had 25% and PCAL-DSK2-1 had 43% large-budded cells (Fig. 5 C) . DAPI staining of the overexpressed DSK2 strains indi- Figure 8 . EM of a dsk2zl rad23A strain and DSK2-1 overexpression strain. A dsk2/l rad23A strain (A and B) was grown at 37°C for 8 h and a PCAL-DSK2-1 strain (C and D) was grown in galactose for 6 h. Cells from both cultures were prepared for EM. Large-budded cells were chosen for analysis, and serial sections surrounding the SPB were examined. In 7 out of 11 large-budded dsk2A rad23A cells, a single SPB was observed spanning two to four serial sections. No additonal SPBs were observed in either neighboring sections or at the opposite end of the nuclear microtubule bundle. Two examples are shown in A and B. In three cells, duplicated SPBs were observed on the opposite side of the nucleus, at the other end of the nuclear microtubule bundle, indicating that a bipolar spindle had formed. In one cell, a duplicated SPB was found adjacent to the first SPB. These results indicated that the monopolar largebudded dsk2A rad23A cells were blocked in SPB duplication and not in SPB separation. The SPBs in serial sections of 12 large-budded cells overexpressing DSK2-1 were also scored by the above criteria. Nine large-budded cells contained a single SPB (two examples are shown in C and D), and three contained a bipolar spindle. These results indicate that overexpression of Dsk2-1p also caused a block in SPB duplication and not in SPB separation.
cated that nuclei in the large-budded cells had an abnormal nuclear position in the neck of the cell (Fig. 9 , E and H). Immunofluorescent staining of tubulin of these cells indicated that overexpression of DSK2+ blocked cells with a short bipolar spindle (Fig. 9, E and F) . Immunofluorescent staining of the anti-90 kD protein indicated that the percentage of cells with one SPB was lower than wildtype, and there was an increase in cells with two SPBs (Fig.  5 C) . Therefore, the overexpression of DSK2+ causes the accumulation of cells with short spindles. In contrast, antitubulin staining of the overexpressed DSK2-1 large-budded cells indicated that they contained a monopolar spindle (Fig. 9 /) as defined by the single vertex of tubulin staining on the edge of the nucleus (Fig. 9 H) . When immunofluorescent staining of the anti-90-kD protein was performed on these cells, we found an increased percentage of cells with a single SPB compared to wild-type cells (Fig. 5 C) .
To confirm that the single SPB observed by immunofluorescence was due to a block in SPB duplication, serial section EM was performed on cells overexpressing DSK2-1. Serial sections of twelve large-budded cells that contained a single nucleus were followed through six to fifteen sections. Nine of the cells (75%) contained a single SPB (Fig.  8, C and D) . The three other cells contained duplicated SPBs that were separated to opposite poles of the nucleus. The percentage of cells with a single SPB determined by EM (75%) correlated well with the percentage of cells containing a monopolar spindle determined by immunofluorescence (69%). Therefore, overexpression of DSK2-1 also caused a block in SPB duplication.
To determine whether the SPB duplication defect could be due to Cdc31p mislocalization, immunofluorescent staining of anti-Cdc31p was performed on these strains. In all cases, anti-Cdc31p staining corresponded to the 90-kD staining (data not shown, but e.g., see Fig. 7 L) , indicating that Cdc31p localization at the sole SPB was not affected.
DSK2, CDC31, and K A R l Interactions
We previously determined that Karlp and Cdc31p physically interact, and that the function of Karlp in SPB duplication is to localize Cdc31p to the SPB (Biggins and Rose, 1994) . To determine the relationship of the DSK2 gene to the K A R l and CDC31 genes, we tested genetic interactions between these genes. First, we tested for genetic interactions between dsk2A and karlA17 since DSK2 is not an essential gene. A dsk2A karlA17 strain was generated and grew normally at 23 ° and 30°C. When the strain was tested for growth at 37°C, it was still temperature sensitive due to the karlA17 allele, indicating that there is no genetic interaction between the dsk2A and kar1A17 at any temperature (data not shown). Since we found that the DSK2 and RAD23 genes are functionally redundant, we tested whether the RAD23 gene interacted with karlA17. A rad23A kar1A17 strain was generated, and like the karlA17 dsk2A strain, the rad23za did not display any genetic interactions with karlA17 (data not shown). We predicted that a kar1A17 dsk2A rad23A strain would exhibit a synthetic effect if the K A R l , DSK2, and RAD23 genes genetically interact to initiate SPB duplication. We therefore generated a kar1A17 rad23A dsk2A strain and found it is temperature sensitive at 37°C (Table II) , indicating that the dsk2A rad23A double deletion and karlzal7 do not suppress each other. Strikingly, however, the triple deletion strain is now temperature sensitive for growth at 33°C (Table II) , a temperature permissive for the kar1A17 (Table II) and the dsk2A rad23za strains (Table II) . This synthetic phenotype suggests that Dsk2p/Rad23p affect cell function in a manner related to Karlp function.
We previously proposed that the CDC31 alleles may suppress karl mutants via an increased interaction with another SPB component since CDC31 suppressor mutations restore the localization of Cdc31p to the SPB in a karl deletion strain (Vallen et al., 1994; Biggins and Rose, 1994) . We therefore tested whether the DSK2 mutations also restore Cdc31p localization to the SPB in a karl deletion strain. Indirect immunofluorescence was performed on a karlzl2 DSK2-1 strain (MS2645) to localize Cdc31p. As shown in Fig. 10, Cdc31p staining (B) corresponds to the 90-kD staining (C) in the karlA DSK2-1 strain, showing that DSK2-1 relocalizes Cdc31p to the SPB in the absence of karl. If Dsk2p is the component that CDC31 suppressors interact with to bypass K A R l function, then DSK2 should be required for CDC31-16 to suppress kar1A17. However, we constructed a CDC31-16 dsk2A karlA17 strain and found that CDC31-16 suppressed karlA17 in either the presence or absence of DSK2+ (data not shown). This indicates that Cdc31-16p suppression of karlA17 occurs either by interacting with factors in addition to Dsk2p or independent of Dsk2p. One potential candidate for this factor is the RAD23 gene that is functionally redundant with DSK2. We therefore tested whether the CDC31 suppressors can suppress the temperature sensitivity in a kar1A17 dsk2A rad23za strain. The CDC31-16 allele (Table I1 ) and high copy CDC31+ (Table II) both suppress the triple deletion strain at 33°C and 35°C. As was found for the dsk2A rad23A strain, CDC31 suppressors did not suppress the dsk2A rad23A kar1A17 strain at 37°C (Table II) . These data show that RAD23 and DSK2 are not required for CDC31 suppression of karlza17, nor is K A R l required for suppression of rad23A dsk2A. Taken together, these results indicate that K A R l , RAD23, and DSK2 functions are mediated through the CDC31 gene.
We next tested the genetic interactions between the DSK2-1 and CDC31-16 suppressors of kar1A17. Although CDC31-16 is a dominant suppressor of the temperaturesensitive kar1A17 mutation (Vallen et al., 1994) , it is a recessive temperature-sensitive mutation in a wild-type K A R l + background. In addition, CDC31-16 causes supersensitivity to the dosage of wild-type K A R l + , even a single extra copy of K A R l + is toxic in a CDC31-16 mutant. When DSK2-1 on a low copy plasmid was transformed into a CDC31-16 strain, very few transformants were obtained. However, many transfromants were obtained when the CDC31-16 mutant was transformed by either the plasmid vector or a low copy plasmid containing DSK2+. Furthermore, many transformants were obtained when an equivalent amount of the DSK2-1 plasmid was transformed into the CDC31 wild-type strain. Therefore, the DSK2-1 allele was toxic in the presence of the CDC31- Figure 10 . DSK2-1 relocalizes Cdc31p to the SPB in a karl mutant strain. Indirect immunofluorescence was performed on a karl deletion strain kept alive by the DSK2-1 suppressor. The anti-Cdc31p staining (B) corresponds to the anti-90-kD staining (C) on the nucleus as determined by DAPI staining (A).
16 allele, in the same fashion as increased dosages of K A R l + (Vallen et al., 1994) . We also tested the toxicity of DSK2-1 to other cdc31 mutant alleles and found that it is toxic to cdc31-2 but not to cdc31-1 or cdc31-5. Strikingly, the CDC31-16 and cdc31-2 alleles both map to the COOH-terminus of Cdc31p, a region previously identified as critical to CDC31 suppression of karlA17 (Vallen et al., 1994) . DSK2-1 did not suppress the temperature sensitivity of any of the cdc31 mutants, supporting the hypothesis that Cdc31p acts downstream of Dsk2p.
Dsk2p Is a Nuclear-enriched Protein
Since DSK2-1 restores Cdc31p localization to the SPB in a karl deletion, we wanted to determine whether it is a SPB component that interacts with Cdc31p. Affinity-purified anti-Dsk2p antibodies were used for indirect immunofluorescence on wild-type and dsk2A strains. D A P I staining was used to visualize the nucleus, and anti-tubulin staining was used to visualize the microtubules. Cells were processed by both formaldehyde fixation and the methanolacetone method of Rout and Kilmartin (1990) and showed the same result. Dsk2p staining appeared to be nuclear enriched (Fig. 11 A, right) , as determined by colocalization with the D A P I staining in wild-type cells (Fig. 11 A , middle) and the lack of staining in the dsk2 deletion cells (Fig.  11 B, right) In addition, there is a cytoplasmic pool of Dsk2p. That the nuclear staining was not due to bleedthrough of the D A P I staining was demonstrated by performing anti-Dsk2p staining without D A P I staining (data not shown). To determine if the localization of Dsk2-1p might be different than the wild-type protein, indirect immunofluorescence was also performed on a DSK2-1 strain. Like the wild-type protein, Dsk2-1p was a nuclear protein (data not shown).
To determine whether Dsk2p might be a SPB component that is not detectable by immunofluorescence due to the large nuclear pool of Dsk2p, a Western blot was performed on partially purified SPBs. Equal amounts of each fraction of the purification (see Materials and Methods for details) were Western blotted with anti-Dsk2p (Fig. 11 D) and anti-Cdc31p (Fig. 11 C) antibodies. The Dsk2 protein appeared enriched in the nuclear fraction (Fig. 11 D, lanes  6 and 7) , but it was not detectable in the SPB fractions (Fig. 11 D, lanes 12 and 13) . However, Cdc31p, a component of the SPB (Spang et al., 1993; Biggins and Rose, 1994) , was detectable in both the nuclear (Fig. 11 C, lanes 6 and 7) and SPB fractions (Fig. 11 C, lanes 12 and 13) . We conclude that Dsk2p is a nuclear-enriched protein that is probably not a component of the SPB.
D i s c u s s i o n Dsk2 Is a Ubiquitin-like Protein
We cloned the DSK2 suppressor of kar1A17 by suppression of the temperature-sensitive defect and found it encodes a novel ubiquitin-like protein containing an NH2-terminal domain homologous to ubiquitin and a novel COOH-terminal domain. Ubiquitin-like proteins have been identified in many other organisms, such as the human BAT2 and BAT3 genes in the major histocompatibility complex (Banerji et al., 1990) . However, although numer-ous ubiquitin-like proteins have been identified, their mechanism of action remains unknown.
We determined that like Rad23p, the NH2-terminal domain of Dsk2p is not cleaved from the protein. Therefore, Dsk2p cannot be posttranslationally conjugated to substrate proteins like ubiquitin to cause substrate degradation or modification. Since the DSK2 suppressor mutations mapped to the ubiquitin-like domain, we tested whether this domain was sufficient for DSK2 suppression of kar1A17. Although the ubiquitin-like domains were expressed at levels comparable to the full-length protein (data not shown), neither the DSK2+ nor DSK2-1 ub-like domain could suppress karlA17. Therefore, unlike ubiquitin, the COOH-terminal domain of Dsk2p is required for protein function.
The DSK2-1 and DSK2-2 suppressor mutations of karlA17 both changed amino acid 69 from histidine to tyrosine in the ubiquitin-like domain. This residue, which corresponds to amino acid 68 in ubiquitin, is conserved in ubiquitin and is important for the proteasomal degradation of polyubiquitinated substrates (Ecker et al., 1987) . In a previous study, a mutation in this residue in ubiquitin decreased the proteolysis rate of substrates to 30% of wild type (Ecker et al., 1987) . Dsk2p and Cdc31p have extremely long half-lives, and the DSK2-1 mutation did not alter the stability of these proteins. In addition, we could not detect ubiquitinated forms of either Cdc31p or Dsk2p (data not shown), indicating that these proteins probably are not degraded by the ubiquitin pathway. Therefore, if the DSK2-1 mutation alters proteolysis, it must change the stability of an unknown protein.
DSK2 Is Involved in SPB Duplication
Since a dsk2 deletion has no obvious phenotype, we tested whether this is due to functional redundancy with the other ubiquitin-like gene in yeast, RAD23, originally isolated in a screen for UV-sensitive mutants. A dsk2 rad23 double deletion strain is temperature sensitive due to a defect in SPB duplication. In contrast to the karlzal7 allele, which is defective for the maintenance of Cdc31p localization at the SPB (Biggins and Rose, 1994) , Cdc31p was still localized at the single SPB. However, since CDC31-16 and high copy CDC31 + can suppress the temperature sensitivity of rad23za dsk2A, their function must be mediated in concert with Cdc31p. In addition, since CDC31 alleles suppress the dsk2za rad23A strain and DSK2 alleles cannot suppress cdc31 mutants, CDC31 must function downstream of these genes for SPB duplication.
Unlike the rad23 mutant, the dsk2A does not exhibit UV sensitivity. In addition, in a dsk2 tad23 double deletion strain, UV sensitivity was equivalent to rad23za, so it is unlikely that they share functional redundancy for DNA repair. Therefore, we propose that the two known yeast ubiquitin-like proteins are involved in SPB duplication, and RAD23 has an additional role in DNA repair.
In addition to the defect in SPB duplication when dsk2 and tad23 are deleted, we found that overexpression of DSK2 and DSK2-1 causes toxicity. The overexpression of DSK2+ causes cells to accumulate with short bipolar spindles, while overexpression of DSK2-1 causes a block in SPB duplication. Therefore, the overexpression of the mutant DSK2-1 causes an earlier cell cycle block than overexpression of wild-type DSK2. Since neither loss of function nor gain of function dsk2 mutants lead to a perfectly uniform arrest in the cell cycle, Rad23p/Dsk2p may have multiple roles throughout the cell cycle. This hypothesis is consistent with the finding that wild-type and DSK2-1 overexpression block at different stages.
The overexpression of KARl + ) also causes toxicity when overexpressed, probably due to the formation of a large aggregate that contains Karlp and Cdc31p (Biggins and Rose, 1994) . Although overexpressed Dsk2p forms aggregates throughout the cell, we could not detect the presence of Cdc31p in these aggregates (data not shown). Therefore, although we did not determine the mechanism by which overexpression causes a block in SPB duplication, the dosage of DSK2 is critical for accurate SPB duplication.
Models for DSK2 Suppression of karl
Like the CDC31 suppressors of karlA17, the DSK2-1 suppressor restores the localization of Cdc31p to the SPB in a karl mutant. Dsk2-1p may relocalize Cdc31p to the SPB by either directly physically interacting with Cdc31p or by indirectly assisting Cdc31p localization. Although Dsk2p is a nuclear protein, it might transiently interact with the SPB to localize the Cdc31 protein. We used several techniques to determine whether Dsk2p and Cdc31p interact physically. First, no binding was observed in a gel overlay assay in which radiolabeled Cdc31p was used to probe immobilized bacterial and yeast Dsk2p and Dsk2-1p (data not shown; Biggins and Rose, 1994) . Second, Dsk2p, Dsk2-1p, and Cdc31p did not coimmunoprecipitate from yeast. Finally, Dsk2p and Cdc31p did not coaggregate in vivo into a complex formed by overexpression of Dsk2p (data not shown). Therefore, Dsk2p and Cdc31p may transiently interact in vivo but probably do not form a stable complex.
We previously proposed that CDC31 suppressors may bypass KARl function due to increased interaction with another unknown protein (Vallen et al., 1994; Biggins and Rose, 1994) . Here we showed that DSK2 function is not required for CDC31-16 to suppress karlA17. However, a kar1A17 dsk2A rad23A strain is very temperature sensitive, indicating that these three genes affect a common function. Because both CDC31-16 and high copy CDC31+ can suppress the temperature sensitivity of this strain, the karlza17 dsk2A rad23A strain is specifically defective for CDC31 function. Furthermore, neither Dsk2p nor Rad23p are required for Cdc31p suppression of karlA17. Therefore, as is the case for KARl, CDC31 gene function must be downstream of DSK2, and there must be at least one additional factor with which Cdc31p suppressors show an altered interaction to suppress karl mutations. The CDC31-16 allele is sensitive to the dosage of DSK2-1, just as it is sensitive to the dosage of KARl+. In addition, DSK2-1 is also toxic to the cdc31-2 allele, another COOH-terminal cdc31 mutation. This region was previously determined to be critical to the CDC31 mechanism of karlza17 suppression (Vallen et al., 1994) . Therefore, CDC31 is sensitive to the dosage of DSK2, suggesting some type of interaction between the DSK2 and CDC31 genes. Taken together, these data suggest that DSK2 mediates most of its functions through CDC31.
Dsk2p is a novel ubiquitin-like protein that has a role in SPB duplication. The DSK2-1 suppressor exhibits many phenotypes similar to the K A R l gene and can relocalize Cdc31p to the SPB in a karl deletion strain. Since Dsk2p is a nuclear-enriched protein that acts upstream of CDC31 in the SPB duplication pathway, we propose that Dsk2p may have a chaperone-like role similar to Rad23p and assist Cdc31p assembly into a new SPB. Since the dsk2A rad23A strain that blocks SPB duplication at 37°C did not affect the localization of Cdc31p at the sole SPB, DSK2 function may not affect the old SPB. Therefore, we propose that Dsk2p is involved in the assembly of a new SPB, and Rad23p may be either directly involved in this process or else be able to functionally substitute for Dsk2p.
